NCT01574677 Assessment of Septin9 Biomarker for Detection of Colorectal Cancer in Patients With Positive Fecal Immunochemical Test Status WITHDRAWN Phase N/A
NCT01570010 The Norwegian Dietary Guidelines and Colorectal Cancer Survival Study Status ACTIVE_NOT_RECRUITING Phase NA
NCT01566942 FOLFIRI or mFOLFOX6 in Adjuvant Chemotherapy in Advanced Colorectal Cancer Status UNKNOWN Phase PHASE3
NCT01558583 Online Study of Colorectal Cancer and Prostate Cancer Screening Decision Making Status COMPLETED Phase NA
NCT01555762 An Observational Study of Avastin in First Line in Elderly Patients With Metastatic Colorectal Cancer (CASSIOPEE) Status COMPLETED Phase N/A
NCT01549327 The Effect of a Virtual Navigator on Colorectal Cancer Patient Empowerment Status COMPLETED Phase NA
NCT01549067 The Real Clinical Background of Advanced Colorectal Cancer Treatment Situation Survey Status UNKNOWN Phase N/A
NCT01547923 Pre-therapeutic Identification of Dihydropyrimidine Dehydrogenase Gene (DPD) Deficiency for Predicting Toxicity to Fluoropyrimidines Status TERMINATED Phase NA
NCT01545141 Chemokine-Modulatory Regimen for Recurrent Resectable Colorectal Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT01538550 Pilot Study of a National Screening Programme for Bowel Cancer in Norway Status ACTIVE_NOT_RECRUITING Phase NA
NCT01535040 Memantine Hydrochloride in Helping Cancer Survivors Stop Smoking Status COMPLETED Phase PHASE2
NCT01531777 Dose Finding and Pharmacokinetics/Pharmacodynamics Study of Apatinib in the Treatment of Advanced Colorectal Cancer Status COMPLETED Phase PHASE2
NCT01529164 Efficacy and Safety Study of Recombinant Endostatin Combined With Chemotherapy to Treat Advanced Colorectal Cancer Status UNKNOWN Phase PHASE2
NCT01525940 PillCam Colon Capsule and CT-colonography in the Evaluation of Patients With Incomplete Conventional Colonoscopy Status COMPLETED Phase NA
NCT01523639 A Randomized, Placebo-controlled, Double-blind Phase II Study Evaluating if Glucophage Can Avoid Liver Injury Due to Chemotherapy Associated Steatosis Status TERMINATED Phase PHASE2
NCT01520389 Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment Status COMPLETED Phase PHASE1